Cigna Corp. Stock
Cigna Corp. Stock
A loss of -2.570% shows a downward development for Cigna Corp..
The stock is an absolute favorite of our community with 42 Buy predictions and no Sell predictions.
With a target price of 336 € there is a positive potential of 41.98% for Cigna Corp. compared to the current price of 236.65 €.
Pros and Cons of Cigna Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cigna Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cigna Corp. | -2.570% | -2.312% | 1.132% | -13.076% | 0.917% | -17.212% | 28.238% |
| Centene Corp. | -1.150% | 4.315% | 14.267% | -34.109% | 15.011% | -44.809% | -28.991% |
| UnitedHealth Group Inc. | -1.250% | 0.017% | 0.223% | -42.561% | 4.158% | -36.110% | -0.290% |
| Humana Inc. | -1.390% | 0.807% | 3.762% | -9.707% | 8.015% | -47.920% | -31.839% |
Comments
Cigna Group (NYSE:CI) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its price target lowered by analysts at Robert W. Baird from $372.00 to $315.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CI provided by MarketBeat
Cigna Group (NYSE:CI) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Show more
Ratings data for CI provided by MarketBeat
News
Cigna (CI) Q2 Revenue Jumps 11%
Cigna Group (NYSE:CI), a global health services company offering integrated medical, pharmacy, and specialty care solutions, released its second-quarter earnings on July 31, 2025. The company
